:quality(90)/cloudfront-us-east-1.images.arcpublishing.com/lanacionpy/EDOMCFQ6FJE55CIKCEKN7B5T5Q.jpg)
The local representative of the pharmaceutical company Medigen Vaccine Biologics Corporation (MVC), Dr. Gabriela Horvath, commented that 2,000 doses of the Taiwanese vaccine MVC-COV1901, which is being developed in collaboration with the USA, have arrived in the country. The type of vaccine is protein subunit, the traditional platform.
He mentioned that this is a 100% Taiwanese company that is allied with the National Institutes of Health (NIH) and there is a part of the vaccine that is Spike protein, this part was patented by the INH, so the base of the vaccine is the same as the Modern one.
“It is here that Moderna has this same base and Medigen took the license of this patent and from this base, it makes its vaccine. The base of the vaccine is the same as that of Moderna, the vaccine is very good. accepted, it has few adverse effects. Until yesterday, 700,000 people have been applied to Taiwan. Taiwan’s own president, Tsai Ing-wen, was the first to receive this vaccine, “she told the Nation.
The local Medigen representative noted that what they are going to do is a phase 3 clinical trial to test the effectiveness. He explained that in phase 2 their safety is tested and then, when the vaccines pass the preclinical phase (phase 1 and phase 2), they reach phase 3 which is to test the effectiveness, which is what goes to do with the Faculty of Medical Sciences of the National University of Asunción (FCM-UNA).
“We are working with the FCM-UNA. The main researchers are Prof. Dr. Laurentino Barris, Prof. Dr. Luis Armoa and Prof. Dr. Julio Torales, and the Central Laboratory of Public Health (LCSP) will be doing VOCID’s anti-spike antibodies in the assay, ”he referred.
Read more: Paraguay received 2,000 doses of Taiwanese vaccine to start phase 3 study
He also indicated that in the context of a pandemic it is not ethical to use a placebo as a control, which in other situations would be used, so they will use as an active control the AstraZeneca vaccine that will be provided by the Extended Program. of Immunizations (PAI) and which are subject to this delivery. Once they have that, they’re going to do a press conference on Monday announcing that the clinical trial is starting.
“As it is in collaboration with the Ministry of Health, the National Directorate of Health Surveillance (Dinavisa), Central Laboratory of Public Health (LCSP) and the Extended Program of Immunizations (PAI), on Thursday we must give 1,000 doses of the AstraZeneca to be able to start from next Monday “, he emphasized.
He said they have a website www.separtedelasolucion.com, where people who are interested in participating will be registered and clarified that it is not yet available. It will be open for two weeks for registration and then closed. It advanced that 500 people of Power station and 500 of High Parana will participate.
People who are interested in participating must be over 18 years of age, cannot be breastfeeding or pregnant, no other COVID vaccine should have been given; in the case of the flu vaccine it must have been a month after application. If he had the disease, he must also have spent at least more than a month to be able to participate.
These points will be verified in the process that will be carried out on the people who participate, through an analysis exam that will also include the VOCID because if he is with the disease he cannot participate, he remarked.
Read also: Monday that the application of the first dose would be resumed, says Borba
He finally stated that the idea is to recruit for two weeks, then verify with the inclusion and exclusion criteria to the participants. People with treated underlying diseases are not excluded.
“The first phase is screening, an intense comprehensive physical check-up with blood tests to predict any situation that may occur and from there, if participants have no problems, after 2 weeks the first dose is applied and at 29 days of the first dose the second is applied.In the case of having diabetes or hypertension treated, you can participate, you must be in a stable situation, not that you have recently started treatment.Really 3 months are the most important until in the second dose, “he added.